Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 5 of 25

  2. Leydig cell tumours represent more than 75% of all testosterone-secreting ovarian masses. These benign tumours are frequently occult or very small, but cause dramatic virilization. Chronic hyperandrogenism can al...

    Authors: Giovanna Saraceno, Valeria Barresi, Francesco Trimarchi and Salvatore Cannavo
    Citation: Journal of Ovarian Research 2013 6:43
    Content type: Case report Published on:

  3. The therapeutic value of systematic lymphadenectomy during debulking surgery for ovarian cancer remains controversial. We conduct this meta-analysis ... in patients treated with optimal cytoreduction for ovarian

    Authors: Qingqing Lin, Wenchao Liu, Song Xu, Juan Li and Jinyi Tong
    Citation: Journal of Ovarian Research 2020 13:56
    Content type: Research Published on:

  5. Multiple studies using single-cell RNA sequencing (scRNAseq) have failed to detect stem cells in adult ovaries. We have maintained that two populations of ovarian stem cells including pluripotent, very small embr...

    Authors: Deepa Bhartiya and Diksha Sharma
    Citation: Journal of Ovarian Research 2023 16:29
    Content type: Brief Report Published on:

    The Correction to this article has been published in Journal of Ovarian Research 2023 16:164

  7. Resistance to apoptosis is a major problem in ovarian cancer (OC) and correlates with poor prognosis. ... attenuate TRAIL-induced apoptosis in a variety of cancer cells, including OC cells. OPG-mediated...

    Authors: Denis Lane, Isabelle Matte, Claude Laplante, Perrine Garde-Granger, Claudine Rancourt and Alain Piché
    Citation: Journal of Ovarian Research 2013 6:82
    Content type: Research Published on:

  9. Bevacizumab and gemcitabine are key drugs for treating recurrent epithelial ovarian cancer. However, information about the combination of...

    Authors: Shoji Nagao, Ai Kogiku, Kazuhiro Suzuki, Takashi Shibutani, Kasumi Yamamoto, Tomoatsu Jimi, Miho Kitai, Takaya Shiozaki, Kazuko Matsuoka and Satoshi Yamaguchi
    Citation: Journal of Ovarian Research 2020 13:14
    Content type: Research Published on:

  10. ...4-Methylumbelliferone (4-MU), a hyaluronan (HA) synthesis inhibitor, has antitumor activity in cancer cells. However, few studies have focused on its effects on ovarian cancer. The aim of this study was to ......

    Authors: Ryosuke Tamura, Yoshihito Yokoyama, Hidemi Yoshida, Tadaatsu Imaizumi and Hideki Mizunuma
    Citation: Journal of Ovarian Research 2014 7:94
    Content type: Research Published on:

  12. A 57-year-old post-menopausal woman (gravida 3, para 2, SA1) was referred to our hospital with lower abdominal pain. An ultrasound and MRI showed that the ovary had swollen to 8 cm in size and had a solid lesion....

    Authors: Maho Shimizu, Keitaro Yamanaka, Maho Azumi, Masako Tomimoto, Keiichi Washio, Ryosuke Takahashi, Satoshi Nagamata, Yuka Murata, Yui Yamasaki and Yoshito Terai
    Citation: Journal of Ovarian Research 2021 14:87
    Content type: Case report Published on:

  13. Ovarian adenocarcinoma is not generally discovered in patients until there has been widespread intraperitoneal dissemination, which is why ovarian cancer is the deadliest gynecologic malignancy. Though incomplete...

    Authors: Daniel R Christie, Faheem M Shaikh, John A Lucas IV, John A Lucas III and Susan L Bellis
    Citation: Journal of Ovarian Research 2008 1:3
    Content type: Research Published on:

  14. Emerging evidence identifies enhancer RNAs (eRNAs) as a class of regulatory ncRNAs that can contribute to the transcription of target genes. In this study, we used an integrated data analysis method to identify t...

    Authors: Jiaya Mo, Lianghao Zhang, Huiqing Li, Haoran Duan, Dong Wang, Xiaolei Zhao and Ya Xie
    Citation: Journal of Ovarian Research 2022 15:61
    Content type: Research Published on:

  15. In this study we aimed to identify a prognostic signature in BRCA1/2...mutations to predict disease progression and the efficiency of chemotherapy ovarian cancer (OV), the second most common cause of death from g...

    Authors: Yinglian Pan, Li Ping Jia, Yuzhu Liu, Yiyu Han, Qian Li, Qin Zou, Zhongpei Zhang, Jin Huang and Qingchun Deng
    Citation: Journal of Ovarian Research 2020 13:112
    Content type: Research Published on:

  17. In normal ovarian function a controlled angiogenesis is essential. Several growth factors are involved in this process, such as the vascular endothelial growth factor (VEGF) and nerve growth factor (NGF). The ang...

    Authors: Carolina Vera, Verónica Tapia, Margarita Vega and Carmen Romero
    Citation: Journal of Ovarian Research 2014 7:82
    Content type: Review Published on:

  18. Anti-Her-2 treatment is successfully administered to Her-2 overexpressing breast cancer patients and significantly implicates upon their survival. ... were tested as an option for epithelial ovarian cancer (EOC) ...

    Authors: Sabine Heublein, Thomas Vrekoussis, Doris Mayr, Klaus Friese, Miriam Lenhard, Udo Jeschke and Darius Dian
    Citation: Journal of Ovarian Research 2013 6:6
    Content type: Brief communication Published on:

  21. While metastasis ranks among the most lethal of all cancer-associated processes, on the molecular level, ... , the lack of unambiguous confirmatory evidence in cancer patients has led to persistent challenges to....

    Authors: Loukia N Lili, Lilya V Matyunina, L DeEtte Walker, Stephen L Wells, Benedict B Benigno and John F McDonald
    Citation: Journal of Ovarian Research 2013 6:49
    Content type: Research Published on:

  22. Resistance to apoptosis is a major problem in ovarian cancer and correlates with poor prognosis. Osteoprotegerin ( ... (TRAIL). TRAIL promotes apoptosis in ovarian cancer cells. Ovarian cancer ascites attenuate T...

    Authors: Denis Lane, Isabelle Matte, Claudine Rancourt and Alain Piché
    Citation: Journal of Ovarian Research 2012 5:34
    Content type: Research Published on:

  23. Recent studies suggested that aquaporins 5 (AQP5) was associated with many kinds of cancers and regulated many processes of various kinds of cancer cells. Our previous studies also demonstrated that AQP5 was high...

    Authors: ChunXiao Yan, Yunshan Zhu, Xiao Zhang, Xuejun Chen, Wei Zheng and Jianhua Yang
    Citation: Journal of Ovarian Research 2014 7:78
    Content type: Research Published on:

  25. Recently, long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have been identified as essential biomarkers during development of malignancies. This study was performed to study the roles of lncRNA opa-interacti...

    Authors: Yujue Wang, Lingling Li, Xun Zhang and Xiaolan Zhao
    Citation: Journal of Ovarian Research 2022 15:25
    Content type: Research Published on:

  26. RNA-Seq allows a theoretically unbiased analysis of both genome-wide transcription levels and mutation status of a tumor. Using this technique we sought to identify novel candidate therapeutic targets expressed i...

    Authors: Rebecca A Mosig, Li Lin, Emir Senturk, Hardik Shah, Fei Huang, Peter Schlosshauer, Samantha Cohen, Robert Fruscio, Sergio Marchini, Maurizio D'Incalci, Ravi Sachidanandam, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2012 5:4
    Content type: Research Published on:

  28. Although agonistic autoantibodies against type-1 angiotensin-II receptor (AT1-AA) are frequently detected in women with preeclampsia, the clinical significance of AT1-AA in association with epithelial ovarian cancer

    Authors: Li Song, Su-Li Zhang, Ke-Hua Bai, Jie Yang, Hai-Yan Xiong, Xiao Li, Teng Liu and Hui-Rong Liu
    Citation: Journal of Ovarian Research 2013 6:22
    Content type: Research Published on:

  29. The epithelial-mesenchymal-transition (EMT) is an important step in the invasion and metastasis of cancer. A critical molecular feature of this process ... -cadherin and Snail) in patients with ovarian cancer.

    Authors: Masaaki Takai, Yoshito Terai, Hiroshi Kawaguchi, Keisuke Ashihara, Satoe Fujiwara, Tomohito Tanaka, Satoshi Tsunetoh, Yoshimichi Tanaka, Hiroshi Sasaki, Masanori Kanemura, Akiko Tanabe and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2014 7:76
    Content type: Research Published on:

  32. The aim of the study is to evaluate the risk factors of anastomotic leakage (AL) and develop a nomogram to predict the risk of AL in surgical management of primary ovarian cancer.

    Authors: Ji Hyun Kim, Won Ho Han, Dong-Eun Lee, Sun Young Kim, Kiho You, Sung Sil Park, Dong Woon Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park and Myong Cheol Lim
    Citation: Journal of Ovarian Research 2023 16:85
    Content type: Research Published on:

  33. Tumor microenvironment and chemokines play a significant role in cancer chemoresistance. This study was designed to reveal ... of CXCL2 in platinum resistance in epithelial ovarian cancer (EOC). Differently expre...

    Authors: Sipei Nie, Yicong Wan, Hui Wang, Jinhui Liu, Jing Yang, Rui Sun, Huangyang Meng, Xiaolin Ma, Yi Jiang and Wenjun Cheng
    Citation: Journal of Ovarian Research 2021 14:115
    Content type: Research Published on:

  34. Thrombocytosis is related to tumor stage and survival in ovarian cancer in addition to the common complications of ... prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.

    Authors: Sari Nakao, Takeo Minaguchi, Hiroya Itagaki, Yoshihiko Hosokawa, Ayumi Shikama, Nobutaka Tasaka, Azusa Akiyama, Hiroyuki Ochi, Koji Matsumoto and Toyomi Satoh
    Citation: Journal of Ovarian Research 2020 13:55
    Content type: Research Published on:

  35. A frozen section diagnosis of a borderline ovarian tumor with suspicious features of invasive carcinoma (“at least borderline” or synonymous descriptions) presents us with the dilemma of whether or not to perform...

    Authors: Koen De Decker, Karina H. Jaroch, Joost Bart, Loes F. S. Kooreman, Roy F. P. M. Kruitwagen, Hans W. Nijman and Arnold-Jan Kruse
    Citation: Journal of Ovarian Research 2021 14:139
    Content type: Research Published on:

  36. Ovarian clear cell carcinoma (OCCC) is a rare histologic type of ovarian cancer. There is a lack of an efficient ... for predicting the overall survival (OS) and cancer-specific survival (CSS) in patients with...

    Authors: Qian Chen, Shu Wang and Jing-He Lang
    Citation: Journal of Ovarian Research 2020 13:123
    Content type: Research Published on:

  37. Epithelial-Mesenchymal Transition (EMT) is a transient and reversible (Mesenchymal-Epithelial Transition or MET) process by which epithelial cells acquire mesenchymal cell characteristics including reduced interc...

    Authors: Neda Jabbari, Ashley N Reavis and John F McDonald
    Citation: Journal of Ovarian Research 2014 7:12
    Content type: Research Published on:

  40. Epithelial ovarian cancer (EOC) is a heterogeneous disease with...

    Authors: Takafumi Watanabe, Hideaki Nanamiya, Yuta Endo, Manabu Kojima, Shinji Nomura, Shigenori Furukawa, Shu Soeda, Hirosumi Tamura, Masae Ryufuku, Daisuke Tanaka, Takao Isogai, Jun-ichi Imai, Shinya Watanabe and Keiya Fujimori
    Citation: Journal of Ovarian Research 2021 14:129
    Content type: Research Published on:

  41. Metastatic neoplasms to the ovary often cause diagnostic problems, in particular those large ovarian masses mimicking primary tumors. Most of these tumors arise from digestive system or breast, while 37-year-old ...

    Authors: Nunzia Simona Losito, Cono Scaffa, Monica Cantile, Gerardo Botti, Raffaele Costanzo, Angela Manna, Renato Franco and Stefano Greggi
    Citation: Journal of Ovarian Research 2013 6:34
    Content type: Case report Published on:

  42. The prognostic value and optimal resection outcome related factors of the secondary cytoreduction surgery (SCR) in Platinum-sensitive recurrent ovarian cancer (PSOC) patients were still in doubt....

    Authors: Hongyuan Gu, Rui Zhou, Jing Ni, Xia Xu, Xianzhong Cheng, Yan Li and Xiaoxiang Chen
    Citation: Journal of Ovarian Research 2020 13:70
    Content type: Research Published on:

  43. Isolated superficial inguinal metastases without any extended intra-abdominal spread is a rare event in patients with ovarian carcinoma. Here we report an isolated superficial inguinal metastasis in a patient wit...

    Authors: Xiao-Jun Yang, Fei-Yun Zheng, Yun-Sheng Xu and Rong-Ying Ou
    Citation: Journal of Ovarian Research 2014 7:20
    Content type: Case report Published on:

  46. The addition of bevacizumab to standard chemotherapy prolongs progression free survival in the first line treatment of epithelial ovarian cancer (EOC), but its cost/effectiveness is...

    Authors: Carlotta Defferrari, Sara Campora, Mauro D'Amico, Arnoldo Piccardo, Ennio Biscaldi, Daniela Rosselli, Ambra Pasa, Matteo Puntoni, Alberto Gozza, Alessandra Gennari, Silvia Zanardi, Rita Lionetto, Michela Bandelloni and Andrea DeCensi
    Citation: Journal of Ovarian Research 2012 5:17
    Content type: Research Published on:

  47. Abnormally expressed in various tumors, long non-coding RNAs (lncRNAs) feature prominently in tumor development, yet little is still known regarding the functional roles of lncRNA AFAP1 antisense RNA 1 (AFAP1-AS1...

    Authors: Bao Liu, Li Yan, Yugang Chi, Yuhan Sun and Xiaoyu Yang
    Citation: Journal of Ovarian Research 2021 14:60
    Content type: Research Published on:

  48. There is an urgent need to set up a useful biomarker for ovarian cancer. Galectin-1 is a promising carbohydrate-binding...

    Authors: Mahak Masoodi, Zafar A. Shah, Afaq H. Beigh, Sheikh Zahoor Ahmad, Abdul Wahid Mir, Besina Yasin, Roohi Rasool, Khalid Z. Masoodi and Gull Mohammad Bhat
    Citation: Journal of Ovarian Research 2021 14:123
    Content type: Research Published on:

  49. In order to investigate whether adjuvant chemotherapy is essential for patients with early-stage serous and endometrioid epithelial ovarian cancer, the present study collected data from the...2 tests. Variables w...

    Authors: Shuqing Li and Zhiling Zhu
    Citation: Journal of Ovarian Research 2020 13:91
    Content type: Research Published on:

  50. Anti-VEGF treatment has proven effective in recurrent ovarian cancer. However, the identification of the patients...

    Authors: Christine Vestergaard Madsen, Karina Dahl Steffensen, Dorte Aalund Olsen, Marianne Waldstrøm, Maja Smerdel, Parvin Adimi, Ivan Brandslund and Anders Jakobsen
    Citation: Journal of Ovarian Research 2012 5:23
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us